Keyphrases
Anticancer Activity
16%
Anticancer Immunity
16%
Anticancer Immunotherapy
100%
Antitumor Activity
16%
Breast Cancer Diagnosis
16%
Breast Cancer Treatment
16%
Cancer Causes
16%
Cancer Disease
16%
Cancer Immunotherapy
16%
Chemotherapy
16%
Colon Cancer
16%
Complete Tumor Regression
16%
Cost Reduction
16%
Design Optimization
16%
Difficult-to-treat
16%
Discovery Time
16%
Drug Development
16%
Female Reproductive System
16%
Greater Good
16%
Host Immune Response
16%
Human Immunity
16%
Immune Activation
16%
Immune Activator
16%
Immune Regulation
50%
Immune Stimulator
16%
Immune System
16%
Immunologist
16%
Infectious Diseases
33%
Inhibitory Activity
16%
Interdisciplinary Collaboration
33%
Lung Cancer
33%
Mortality Rate
16%
Nanostructures
100%
New Drug Development
16%
Non-small Cell Lung Cancer (NSCLC)
16%
Novel Nanostructure
100%
Ovarian Cancer
33%
Ovarian Cancer Cells
16%
Patent Application
16%
Poor Outcome
16%
Rational Design
16%
Robust Optimization
16%
Shelf Life
16%
Structural Features
16%
Structural Stability
16%
Student Training
16%
Synergize
16%
Systemic Toxicity
16%
Therapeutic Strategies
16%
Tumor
16%
Tumor Growth
16%
Tumor-bearing Animals
16%
Two-line
16%
Viral Infection
16%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
10%
Chemotherapy
10%
Colon Carcinoma
10%
Diseases
20%
Drug Development
20%
Immunotherapy
100%
Lung Cancer
20%
Malignant Neoplasm
100%
Mortality Rate
10%
Nanomaterial
100%
Neoplasm
30%
Non Small Cell Lung Cancer
10%
Ovary Cancer
30%
Preclinical Study
10%
Side Effect
20%
Tumor Growth
10%
Tumor Regression
10%
Virus Infection
10%
Immunology and Microbiology
Antineoplastic Activity
33%
Cancer Immunotherapy
100%
Colon
16%
Immune System
33%
Immunity
100%
Mortality Rate
16%
Preclinical Study
16%
Tumor Immunity
16%
Viral Disease
16%